Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

REPL

Replimune Group, Inc.

CIK 0001737953 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$14.77
↑ 0.72 (5.12%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals, Options

Key stats

Market Cap
$1.38B
P/E Ratio
-4.66
EPS
-3.38
Dividend Yield
Not covered
52W Position
93%
Beta
1.24

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
13.10
P/S
Not covered
EV/Revenue
Not covered
ROE
-281.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 93%
$1.50$15.71

Latest Financials

2026-03-31 FY
Revenue
–
Net Income
-$313.94M
Total Assets
$332.39M
Free Cash Flow
–

Recent news